StockData
ATRCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

AtriCure, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 27, 2026
$55.53−0.54 (-0.96%)

Close on Oct 19, 2026

Market cap
$2.71B
P/E (TTM)
264.4
Dividend yield
–

Earnings

Next report expected Oct 28, 2026, after market close (estimated from past report dates)

QuarterReportedTimeRevenueEPS (GAAP)EPS (adjusted)
Q2 FY2026
Ended Jun 30, 2026
Jul 23, 2026After market close$153.60M$0.18$0.18
Q1 FY2026
Ended Mar 31, 2026
May 5, 2026After market close$141.20M$0.00$0.00
Q4 FY2025
Ended Dec 31, 2025
Jan 12, 2026Before market open$140.50M––
Q3 FY2025
Ended Sep 30, 2025
Oct 29, 2025After market close$134.30M$-0.01$-0.01
Q2 FY2025
Ended Jun 30, 2025
Jul 29, 2025After market close$136.10M$-0.13$-0.02
Q1 FY2025
Ended Mar 31, 2025
Apr 29, 2025After market close$123.60M$-0.14$-0.14
Q4 FY2024
Ended Dec 31, 2024
Jan 13, 2025Before market open$124.30M––
Q3 FY2024
Ended Sep 30, 2024
Oct 29, 2024After market close$115.90M$-0.17$-0.17
Q2 FY2024
Ended Jun 30, 2024
Jul 30, 2024After market close$116.30M$0.17$0.17
Q1 FY2024
Ended Mar 31, 2024
May 1, 2024After market close–––
Q4 FY2023
Ended Dec 31, 2023
Jan 8, 2024Before market open–––

Company guidance

Outlook given with results on Jul 23, 2026, compared with the previous outlook

MeasurePeriodGuidancevs. prior
adjusted EBITDAnon-GAAPFull year 2026$85.00M to $89.00MRaised
adjusted earnings per sharenon-GAAPFull year 2026$0.24 to $0.32Raised
net income per shareGAAPFull year 2026$0.05 to $0.13New
revenueFull year 2026$602.00M to $610.00MRaised

Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.

Press releases

Announcements AtriCure filed with the SEC